CISA Warns of Critical Flaws in Illumina’s DNA Sequencing Instruments –

CISA has released an advisory warning of critical vulnerabilities in Illumina medical devices that could be exploited to eavesdrop on network traffic and execute arbitrary commands.

The FDA has warned that these flaws could have serious implications, such as incorrect results, altered results, or a potential data breach.

There is no evidence that the vulnerabilities have been exploited in the wild, but users should apply the fixes released on April 5, 2023, to mitigate potential threats.

This is the second time severe flaws have been found in Illumina’s DNA Sequencing Devices and the FDA has issued new guidance that requires medical device makers to adhere to a set of cybersecurity requirements when submitting a new product.

#shorts #techshorts #technews #tech #technology #data #affected product #vulnerabilities

👋 Feeling the vibes?

Keep the good energy going by checking out my Amazon affiliate link for some cool finds! 🛍️

If not, consider contributing to my caffeine supply at Buy Me a Coffee ☕️.

Your clicks = cosmic support for more awesome content! 🚀🌈